BRCA1 and breast carcinoma: Moreover, treatment modalities have improved breast cancer-specific survival for BRCA1/2-related breast cancer over the past several years, with the most recent addition to treatment being the use of poly adenosine diphosphate [ADP]-ribose polymerase [PARP] inhibitors [10].